Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Anatomical Shoulderᵀᴹ 2.0 Fracture System (Implants and Instrumentation) - A Retrospective and Prospective Consecutive Series Study
The study is a multicenter, retrospective and prospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to collect long-term data confirming safety, performance and clinical benefits of the Anatomical Shoulder 2.0 Fracture System (Implants and Instrumentation) when used for fracture shoulder arthroplasty. The primary objective is the assessment of safety by analyzing implant survivorship. This will be established by recording the incidence and frequency of revisions, complications and adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified. The secondary objective is the assessment of performance and clinical benefits by recording patient-reported clinical outcome measures (PROMs) as well as radiographic outcomes.
• Patients 18 years or older and skeletally mature
• Patients capable of understanding the surgeon's explanations and following his instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study
• Replacement of the proximal humerus and the glenoid articular surface of the scapula during total-, hemi- and fracture shoulder arthroplasty in treatment of the following:
‣ Complex 3- and 4- part fractures of the proximal humerus with subluxation of the head fragment
⁃ Complex 3- and 4- part fractures of the proximal humerus with loosening of the spongiosa in the head fragment
⁃ Complex 3- and 4- part fractures of the proximal humerus with additional cross split of the head fragment
⁃ Fracture instability after osteosynthesis of 3- and 4-part fracture fragments of the proximal humerus
⁃ Posttraumatic necrosis of the humeral head
⁃ Posttraumatic arthrosis after humeral head fracture